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Background: Engineered zinc-finger nucleases (ZFN) represented an innovative method for the genome
manipulation in vertebrates. ZFN introduced targeted DNA double strand breaks (DSB) and initiated
non-homologous end joining (NHEJ) after pronuclear or cytoplasmatic microinjection into zygotes. Resulting frame
shift mutations led to functional gene ablations in zebra fish, mice, pigs and also in laboratory rats. Therefore, we
targeted the rat Rag1 gene essential for the V(D)J recombination within the immunoglobulin production process
and for the differentiation of mature B and T lymphocytes to generate an immunodeficient rat model in the
LEW/Ztm strain.
Results: After microinjection of Rag1 specific ZFN mRNAs in 623 zygotes of inbred LEW/Ztm rats 59 offspring were
born from which one carried a 4 bp deletion. This frame shift mutation led to a premature stop codon and a
subsequently truncated Rag1 protein confirmed by the loss of the full-length protein in Western Blot analysis.
Truncation of the Rag1 protein was characterized by the complete depletion of mature B cells. The remaining T cell
population contained mature CD4+/CD3+/TCRαβ+ as well as CD8+/CD3+/TCRαβ+ positive lymphocytes
accompanied by a compensatory increase of natural killer cells in the peripheral blood. Reduction of T cell
development in Rag1 mutant rats was associated with a hypoplastic thymus that lacked follicular structures.
Histological evaluation also revealed the near-complete absence of lymphocytes in spleen and lymph nodes in the
immunodeficient Rag1 mutant rat.
Conclusion: The Rag1 mutant rat will serve as an important model for transplantation studies. Furthermore, it may
be used as a model for reconstitution experiments related to the immune system, particularly with respect to
different populations of human lymphocytes, natural killer cells and autoimmune phenomena.
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Several modern techniques facilitate the genetic manipu-
lation of the rat genome in vivo. Aside from the pro-
nuclear injection of recombinant DNA constructs, the
integration of lentiviral vectors into the rat genome after
injection into the perivitelline space and transposon-
mediated insertions have enabled studies in transgenic
rats [1-5]. Random integration of Sleeping Beauty and
PiggyBac transposons caused gene inactivation at the in-
tegration sites [6,7]. Moreover, the cultivation of rat em-
bryonic stem cells does allow gene targeting and* Correspondence: Zschemisch.Nils-Holger@mh-hannover.de
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distribution, and reproduction in any mediumfunctional deletion through homologous recombination
(HR) in vitro [8-11]. However, due to the technical com-
plexity of these procedures only the p53 gene and the
Par-2 gene have been inactivated through HR in ES cells
to date [12,13]. Alternative strategies for the functional in-
activation of genes use the highly efficient Zinc-finger nu-
clease (ZFN) [14] and transcription activator-like effector
nucleases (TALEN) technologies [15], both of which offer
a rapid approach in gene targeting. Zinc-finger nucleases
are hybrid proteins consisting of polymeric zinc-finger
proteins fused to the endonuclease domain of the restric-
tion enzyme FokI. A pair of zinc-finger nucleases binds to
two contiguous target sequences in each DNA strand
separated by a 6 bp cleavage site. Subsequent dimerization
of the FokI domains causes DSB and initiate endogenousntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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to DNA damage introduce deletions or insertions in the
spacer region. The resulting frame shift leads to a prema-
ture stop codon and the translation of a truncated, in-
active protein [16,17]. Therefore, ZFN have been used
for the manipulation of human and rodent cells in vitro
[18-20] as well as for gene targeting or for homology
directed repair in zebra fish, mouse, rat and pig embryos
in vivo [21-25]. In the rat, genes such as immunoglobulin
heavy chain 6 (Igh-6), immunoglobulin heavy chain
(gamma polypeptide) (JH locus), transgenic eGFP, renin
(Ren), interleukin 2 receptor gamma (Il2rg), ATP-binding
cassette, sub-family B (MDR/TAP), member 1A (Mdr1a)
and Rab38 have been successfully inactivated by ZFN
mediated gene disruption in single cell embryos [26-30].
Here we report about generating a Rag1 knockout
by ZFN in LEW rats, with the intention of establishing
an immunodeficient rat model on a defined genetic
background.
Rag1 as well as Rag2 are highly conserved genes
located in close vicinity in head to tail arrangement on
chromosome 11p13 in humans, on chromosome 2qE2 in
the mouse, and at chromosome 3q31 in the rat. In
humans, Rag1 mutations lead to severe combined im-
munodeficiency (SCID) due to B and T cell loss (T-B-
SCID) or Omenn’s Syndrome (T+B-SCID) with a shor-
tened life expectancy reviewed in [31-34]. A similar











Figure 1 Introduction of a frame shift mutation. A The 11097 base pair
contains the complete coding sequence (red bar). Rag1 specific zinc-finger
cutting site between position 5233 and 5267 introduced DSBs through the
digest of the 310 bp heteroduplex DNA derived from the hybridization of
136 bp fragments proofed the mutagenesis of one Rag1 allele in founder 5the mouse with an arrest of B and T precursor cells in
an early developmental stage, no serum IgG and an ele-
vated number of natural killer cells (NKC) [35-38].
The generated Rag1 mutant rat on a defined genetic
background can provide a useful tool for studies of the
immune system, in transplantation studies, and in auto-
immune diseases.
Results
Embryo manipulation and Rag1 gene targeting
A pair of zinc-finger nucleases consisting of five zinc-
finger modules recognizing 15 bp at both sides of a 6 bp
cut side located close to the 5’ end of Exon 2, were used
to induce DSBs and NHEJ in the Rag1 gene (Figure 1A).
The injection of the Rag1 specific ZFNs into 623 zygotes
harvested from 35 hyperovulated donors resulted in 444
morphologically intact embryos transferred to 19 pseu-
dopregnant (LEW x WKY) F1 females. From the
59 pups born, 49 survived the weaning period.
Surveyor mutation detection assay was performed to
identify offspring carrying a Rag1 mutation by cutting of
heteroduplex DNA derived from hybridization of wild
type LEW/Ztm DNA with founder DNA through the
Cel-I endonuclease [39,40]. Analysis of the offspring
revealed partial cleavage of the 310 bp hybrid DNA into
174 bp and 136 bp fragments in one female (denomi-
nated “founder 58”), giving a 1.7% rate of transgenesis of
the Rag1 gene (Figure 1B).310 bp
174 bp
136 bp








s of genomic Rag1 are separated in two exons. Of these only Exon 2
nucleases recognizing 18 bp upstream and downstream of the 6 bp
FokI endonuclease domain and initiated NHEJ. B Cel-I endonuclease
the DNA from LEW wild type rats and founder 58 into 174 bp and
8. G/C: heteroduplex control DNA; LEW: LEW/Ztm wild type DNA.
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Sequencing of exon 2 of the Rag1 gene from “founder
58” verified an A to C base exchange at position 5244
combined with a 4 bp deletion at position 5246 – 5249
while mutations were absent on the second allele
(Figure 2 A). The 4 bp deletion in the Rag1 gene of
“founder 58” caused a frame shift mutation and gener-
ated a premature stop codon at position 667 of the Rag1
mRNA, thereby encoding a truncated 198 aa protein.
This shortened protein was homologous to the
N-terminal part of wild type Rag1 but lost the zinc-
binding dimerization domain (ZDD) and the c-terminal
Core domain of the 1040 aa full length protein [38]
(Figure 2B). No off-target mutations were seen in the 10ZDD262 380









Figure 2 Analysis of the mutant Rag1 allele. A Heterozygosity at the ge
start of the mixed signal indicated the Rag1 mutation identified as A to C e
(red lower case) and the ZFN binding regions (black upper case). The intro
truncation of the Rag1 protein to a 198 aa N-terminal residue. B Full length
dimerization domain (ZDD) containing the RING finger (RING) and the zinc
nonamer-binding region (NBR) and the zinc finger B (ZFB). Mutated Rag1 loloci with the highest sequence homology to the zinc-finger
binding and cut site in the Rag1 gene by the SURVEYOR
mutation detection assay in “founder 58” (Figure 3).
Germ line transmission and genotyping
Subsequently, the heterozygous “founder 58” was mated
to a wild type LEW male to evaluate germ line transmis-
sion and to establish the novel Rag1 deficient LEW/
Ztm-Rag1em1Ztm coisogenic strain. To distinguish be-
tween wild type and heterozygous pups, we used the loss
of the recognition site of the restriction endonuclease
StyI caused by the 4 bp deletion in Exon 2 of Rag1.
Therefore, genotyping was performed by PCR amplifica-
tion of a 1052 bp sequence of Rag1. While the PCRCore Rag1




nomic Rag1 locus of founder 58 was confirmed by sequencing. The
xchange (green upper case) plus 4 bp deletion at the ZFN cut site
duced frame shift caused a premature stop codon leading to a
Rag1 protein consists the functional important zinc-binding
finger A (ZFA) as well as the c-terminal core domain with the
st all domains essential for Rag1 function in V(D)J recombination.




Figure 3 Off-target mutation analysis. A Cel-I digest of heteroduplex DNA revealed no additional off-target mutations at the 10 loci with
highest homology to Rag1; 1: Vom2r-ps62; 2: Atrn; 3: Vwa5b1; 4: KIAA2012; 5: Zfn9; 6: Dctn1; 7: Mylip; 8: Manl1; 9: LOC689553; 10: Kir3d1l; G/C:
control heteroduplex DNA. B Genes, gene IDs, sequence homologies and localization of Rag1 related sequences to exclude off-target mutations;
upper case: ZFN binding sites; lower case: ZFN cut site; homolog base pairs in red; (-): Gene located on the minus strand.
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603 bp and 449 bp fragments by StyI, mutated Rag1 sec-
tions remained uncut. Six out of 11 offspring were het-
erozygous, demonstrating germ line competence and
confirming the heterozygosity of “founder 58”
(Figure 4A). Offspring carrying the mutation was used
for further breeding. Heterozygous LEW/Ztm-
Rag1em1Ztm rats showed normal reproduction with litter
sizes ranging from 6 to 12. The mutation was inherited
in the expected Mendelian ratio.
Macroscopical and histological evaluation
Phenotypical characterization revealed no ontogenetic
disorders despite of underdeveloped thymi of the Rag1
mutant rats (Figure 4B and C). The mean thymus weight
was significantly reduced from 0.44 g (SD ±0,04) in wild
type and 0.45 g (SD ±0,05) in heterozygous animals to
0.06 g (SD ±0,01) in homozygous Rag1 mutant rats
(Figure 4D and E). The reduced size of the thymus of
Rag1 mutant rats was associated with a complete loss of
the follicular structure showing the absence of T lym-
phocytes (Figure 5B). Histological evaluation of the
spleen demonstrated the differentiation in red and white
pulp containing B cells in the lymphatic follicles and T
lymphocytes in the periarteriolar lymphoid sheaths
(PALS) in wild type animals (Figure 5C). Besides the
central artery the follicles of the white pulp are reducedand the PALS were lost in rats with partial Rag1 inacti-
vation (Figure 5D). In wild type lymph nodes the cortex
was characterized through trabecular structures separat-
ing follicles where B cell differentiation occurred in the
germinal centers (Figure 5E). The lymph nodes of homo-
zygous LEW/Ztm-Rag1em1Ztm rats appeared devoid of T
and B lymphocytes and follicular structures, in which
physiological B cell differentiation would occur, were ab-
sent (Figure 5F). No further macroscopic differences in
organ size and structures were found in homozygous
LEW/Ztm-Rag1em1Ztm rats, and careful histological
evaluation revealed no malformation of organs outside
of the lymphatic system.Disruption of wild type Rag1
Molecular characterization by RT-PCR showed a shift
from the expression of wild type Rag1 mRNA in the
lymphatic organs of wild type rats to the exclusive ex-
pression of mutated Rag1 in knockout rats. In heterozy-
gous animals wild type and mutated Rag1 were
transcribed equally (Figure 6A). Western Blot analysis
confirmed the loss of full length Rag1 protein in the thy-
mus of homozygous mutant rats, while heterozygous
animals exhibited a significant reduction of the Rag1
protein concentration as compared to the strong transla-
tion of Rag1 in wild type rats (Figure 6B).








Figure 4 Genotyping and macroscopical examination. A Genotyping of the offspring derived from founder 58 using PCR amplification and
StyI-HF digest. Half of the 1052 bp PCR products from heterozygous animal are digested into 603 bp and 449 bp fragments, while the Rag1 PCR
product from wild type offspring was digested completely; N: negative control. 58: PCR product from founder 58 as positive control. B Normal
thymus of wild type animal of the strain LEW-Rag1em1/Ztm-RaglemlZtm. C Hypoplastic thymus in a Rag1 mutant rat. D Comparison of the thymus
sizes of wild type and Rag1 mutant rats. E Comparison of thymus weigths, *** : P < 0.0001.
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The quantity of B and T lymphocytes, as well as NKC
was determined by FACS analysis. The fraction of B cells
in peripheral blood was almost identical in wild type and
heterozygous animals with a mean of 18,1% (SD ± 3,4%)
and 13% (SD ± 2,5%). B cells were absent in Rag1 homo-
zygous mutant rats (Figure 6C; 7A-C). Further, the ratio
of T cells was almost the same in wild type and heterozy-
gous rats with 60,9% (SD ± 4,1%) and 69,5% (SD ± 6,9%),
however in rats with deficiency of full length Rag1 T cells
were significantly reduced with 4,6 (SD± 5,7%)
(Figure 6C; 7A -C). Inverse ratios were found when
counting NKC. While in wild type and heterozygous rats
only 2,2% (SD ± 0,7%) respectively 2,2% (SD ± 1,2%) of
NKC could be detected, the peripheral blood of Rag1
mutant rats contained 15,3 ± 7,5% NKC suggesting a
compensatory increase of natural killer cells (Figure 6C;
7A -C). Further analysis revealed that the T cell popula-
tion isolated from the peripheral blood of rats withhomozygous Rag1 frame shift mutation consisted of ma-
ture CD4+/CD3+/TCRαβ+ and CD8+/CD3+/TCRαβ+ thy-
mocytes (Figure 8).
Discussion
Low efficiency of Rag1 specific ZFNs in LEW/Ztm rats
The most striking advantage of the ZFN technology is
the capability to manipulate embryos of any species.
Nevertheless, the efficiency of the genetic manipulation
may be modulated by strain variations and species differ-
ences, as well as locus specific chromatin structure and
technical setup. In LEW/Ztm 71,3% of the injected
embryos were still viable and resulted in 13,3% live
births. However, only 1,7% carried the expected Rag1
mutation. In contrast to this the workgroup at the SAGE
Lab, which used the identical ZFN mRNAs for the dis-
ruption of Rag1 in SD rats achieved a ratio of 20% of
Rag1 mutated rats (5 out of 24 pups born, personal
communication).







Figure 5 Histological evaluation of lymphatic organs of wild type and Rag1 mutant rats. A and B thymus; C and D spleen; E and
F lymph nodes. H/E staining.
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the mutation) seen in the targeting of the Renin gene in
inbred SS (salt-sensitive) rats [30] was at a similar low
level as the ablation of Rag1 in the LEW/Ztm back-
ground. Guerts and coworkers found survival rates com-
parable to the LEW rat with 56% to 91% after
microinjection of ZFN encoding plasmids or ZFN mRNA
in the SD background. The ratio of live-born pups born
(13 - 20%) also correlates with our results, however,
the efficiency of the manipulation was much higher in
the SD rats up to 75% mutants [27] instead of 1,7% on
the LEW background. Nevertheless, Mashimo and col-
leagues detected high average ratios of born and mutated
animals with 24,3% and 24,1% after micromanipulation
of zygotes from inbred F344/Stm or TM/Kyo strains to
inactivate the IL2rg gene [28]. However, comparing the
efficiency of the Rag1 mutation in outbred SD and inbred
LEW suggests that the different genetic backgrounds are
an important determinant in the ratio of transgenesis,
even though it also depends on the accessibility of the
gene locus due to the chromatin structure [41].
Further, the conditions of the technical engineering
determined the success of the ZFN mediated gene tar-
geting. Guerts and coworkers showed that the stepwise
increase of the concentration of the injected mRNAs
from 0.4 μg/μl to 2μg/μl and then to 10 μg/μl correlateswith reduced ratios of born embryos. Among these the
number of mutant offspring increased with the injection
of higher mRNA concentrations in SD rats [27]. There-
fore, the functionality of the individual pair of ZFNs and
the technical setup of the experiment in combination
with the stress sensitive and delicate LEW embryos
might be responsible for the low outcome of Rag1
mutated rats in this study [42]. Future comparison of
identical ZFN in several rat inbred strains will be neces-
sary to validate strain dependent variations of ZFN
mediated manipulation efficiencies.
High fidelity of the Rag1 ZFN
The introduction of genetic modifications in the mam-
malian genome harbors the risk of causing unwanted,
random or off-target mutation. It is well known that
the Cre recombinase widely used for the conditional
deletion of genomic sequences recognizes cryptic
“pseudo-loxP” sites, initiates chromosomal rearrange-
ments and infertility in mice [43,44]. Despite the
high binding specificity of ZFN to their specific target
sequence additional off-target mutations at homologous
loci must be excluded. Neither in our LEW-Rag1 mutant
rat, nor in any other published knockout rat model
created by ZFN-mediated genome modification, off-
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C
Figure 6 Analysis of Rag1 expression in lymphatic organs. RT-PCR of wild type, heterozygous and Rag1 mutant rats: The Rag1 PCR product
(upper panel) was digested with StyI-HF to distinguish between translation of wild type and mutated Rag1 (mid panel). GAPDH used as
housekeeping gene (lower panel). B Western Blot analysis: Translation of Rag1 in the thymus from wild type, heterozygous and Rag1 mutant rats
compared to GAPDH as housekeeping protein. C Comparison of NK cells, B and T cell ratio in the peripheral blood of wild type, heterozygous
and Rag1 mutated rats determined by FACS analysis. *** P < 0.0001; ** P < 0.005.
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tivity [21,26-30].
Leakiness of LEW/Ztm-Rag1em1Ztm
The phenotype of the LEW-Rag1 mutant rat was charac-
terized by a substantial decrease of Rag1 translation in
heterozygous animals and by a complete loss of the
Rag1 protein in the homozygous mutant rats suggesting
a biallelic expression of Rag1 in wild type rats. The ab-
sence of dose dependent effects in the heterozygous ani-
mals emphasized that the translation of Rag1 from only
one allele was sufficient for a functional immune system
while homozygous Rag1 mutation was associated with a
reduction of T cells, complete ablation of B cells and
an elevation of NK cell number in peripheral blooddemonstrated by FACS analysis. The repression of
lymphocyte development due to the lack of V(D)J re-
combination was associated with a hypoplastic thymus
and the loss of follicular structures associated with
lymphocyte maturation in thymus, spleen and lymph
nodes. The underdevelopment of the thymus in the
LEW-Rag1 mutant rat correlates with the reduced size
of the thymus in the Rag1 knockout mouse, where the
substitution of a central part of the coding sequence in
exon 2 through a neomycin resistance cassette led to the
complete functional inactivation of Rag1 [37]. In con-
trast to the non-leaky Rag1 knockout mouse we found
an average of 4,6 % T cell receptor positive thymocytes
while no B cells were found in the LEW-Rag1 mutant
rat. Furthermore, in the SD-Rag1 mutant rat [45] nearly
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Figure 7 FACS analysis of NKC, B and T lymphocytes in the blood: A wild type, B heterozygous and C Rag1 mutant rat; blue: CD161
positive NKC; green: CD45RA positive B cells; red: T cell receptor positive lymphocytes.
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http://www.biomedcentral.com/1471-2172/13/6011% CD3 positive T cells and some CD45RA expressing
B cells were detected. Rag1 deficiency excludes lympho-
cyte maturation as shown in the Rag1 knockout mouse.
T cell precursors mature only up to the double negative
CD4-CD8-IL2R-α positive stage in the absence of murine
Rag1 [35,37]. Therefore, the origin of mature T lympho-
cytes in the Rag1 knockout rat is still unknown as extra-
thymic thymocyte maturation, such as intestinal
intraepithelial TCRγδ+ T lymphocytes (IEL) in BB rats,
CD2+CD7+ preTCRα+ T cells in the adult liver or CD2
+CD7+CD3- T cells in the human small intestine, always
require the expression of functional Rag1 [46-48]. Asimilar frame shift mutations like in the LEW/Ztm-
Rag1em1Ztm were observed in the human Rag1 gene in
two patients with Omenn’s syndrome carrying an adeno-
sine deletion at position 877 of the Rag1 cDNA also
introducing a premature stop codon in front of the non-
amer binding region (NBR) [49,50]. Santagata and col-
leagues showed that in response to the frame shift
mutation truncated Rag1 protein had been translated
from an internal methionine without the N-terminal BIIA
nuclear localization signal. Like in LEW/Ztm-Rag1em1Ztm
homozygous rats, in these patients differentiation of ma-
ture, activated but oligoclonal T cells with impaired
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Figure 8 Mature CD4 or CD8 positive T lymphocytes in the
peripheral blood of Rag1 mutant rats. A Absence of CD4+/CD8+
lymphocytes in wild type and Rag1 mutant rats. B and C Reduction
of CD4+/CD3+ and CD8+/CD3+ T cells. D and E While there are no
differences in the population of CD25+/CD4+ T cells the number of
CD25+/CD8+ lymphocytes was reduced. orange: autofluorescent
cells; green: FITC positive lymphocytes; blue: PE positive
lymphocytes.
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truncated Rag1 and reduced recombinational activity
[49,50]. In the future cloning of the LEW/Ztm-Rag1em1Ztm
allele followed by in vivo translation and recombination
should demonstrate the translation, cellular localization
and functionality of the mutated Rag1 protein in the
LEW/Ztm rats.
Functional compensatory NK cell increase
The elevated NK cell number in the peripheral blood of
LEW/Ztm-Rag1em1Ztm rats correlates with the observation
of an increase in NKC population in spleen, lymph nodes,
lung, and liver of Rag1 knockout mice [36]. Grundy and
Sentman speculate that the NKCs substitute T lympho-
cytes by migration along chemokine gradients into these
organs. The increase in NK cell concentration in the blood
of LEW/Ztm-Rag1em1Ztm mutant rats was also associated
with a reduction of thymocytes, but the molecular path-
ways involved in this compensatory process are still
unknown.
Further characterization of the LEW/Ztm-Rag1em1Ztm
strain as well as xenotransplantation experiments of cells
and tissues will be performed to establish the Rag1 mu-
tant rat as a innovative model for studies in autoimmune
diseases, transplantation approaches and carcinogenesis
as well as cancer therapy.
Methods
Animals
All rats were bred and maintained at the Central Animal
Facility of the Hannover Medical School, Carl-Neuberg-
Strasse 1, 30625 Hannover, Germany (subline code: Ztm:
http://www.mh-hannover.de/einrichtungen/tierlabor).
All handling of animals has been conducted in accordance
with German law for animal protection and with the
European Communities Council Directive 2010/63/EU for
the protection of animals used for experimental purposes.
All experiments have been approved by the Local Institu-
tional Animal Care and Research Advisory committee and
permitted by the local government (Lower Saxony State
Office for Consumer Protection, Food Safety, and Animal
Welfare Service – LAVES; Az.10/0051).
Husbandry
LEW, LEW/Ztm-Rag1em1Ztm, and (LEW x WKY)F1 rats
were maintained under standardized conditions at a
temperature of 22 ± 2°C, relative humidity of 55±5%,
and artificial light for 14h. Commercial softwood granu-
late bedding was sterilized (Lignocel, Altromin; Lage,
Germany). They received an autoclaved commercial pel-
leted diet (Altromin 1314) and water ad libitum. The
rats were kept as pairs or in sibling groups. Microbio-
logical status was monitored according to FELASA
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virus and apathogenic protozoa.Zinc-finger nucleases
Rag1 specific ZFN consisting of 5 zinc-finger modules
fused to the endonuclease domain of the restriction
endonuclease FokI were designed and functionality eval-
uated by Sigma Advanced Genetic Engineering Labs
using the CompoZrW ZFN technology. The forward ZFN
recognized the DNA sequence GTCTACTGCCCAAGG
between positions 5233-5247, while the reverse ZFN
detected the DNA segment GACCGTGGAGTGGCA
located at 5253-5267 in Exon 2 of genomic Rag1 (Rattus
norvegicus strain BN/SsNHsdMCW chromosome 3,
Rnor_5.0: NCBI Reference Sequence: NC_005102.3).
The ZFN binding sites were separated by the 6 bp cut
site. ZFN mRNAs were translated in vitro using the
MessageMax T7 ARCA-Capped Message Transcription
Kit (#MMA60710, Epicentre Biotechnologies, Madison,
WI) and the Poly (A) Polymerase tailing kit (#PAP5104H,
Epicentre Biotchnologies, Madison WI) following the
manufacturer’s recommendations. mRNA quantity was
measured using the Nanodrop spectrophotometer (Peq-
lab, Erlangen, Germany) and sufficient quality was con-
firmed by agarose gel electrophoresis.Embryo collection and manipulation
LEW/Ztm female were hyperovulated as described earl-
ier [52]. Equal amounts of both ZFN mRNAs were
mixed and diluted with injection buffer (1mM Tris-HCl,
pH 7.4; 0.25 mM EDTA) to a final concentration of
5 ng/μl [21]. Estrous in LEW/Ztm was induced by injec-
tion of 50μg LHRH (L 4513, Sigma-Aldrich, Seelze,
Germany) 4 days prior to mating. Zygotes were har-
vested on day 0.5 of pregnancy from the ampullae of
oviducts in M2 medium (M7176, Sigma-Aldrich, Seelze,
Germany) containing 2.2 mg/ml hyaluronidase (9978.1,
Carl Roth, Karlsruhe, Germany) to detach the cumulus
cells. Cumulus cell free zygotes were washed several times
in M2 and than transferred to modified M16 medium
supplemented with 1% non-essential amino acids
(M7145, Sigma-Aldrich, Seelze, Germany) and covered
with mineral oil (Light Mineral Oil EmbryoMaxW, Milli-
pore, Schwalbach, Germany). ZFN mRNAs were microin-
jected with glas capillaries (inner diameter of 1.2 μm,
Pronucleus PI-1.2, BioMedical Instruments, Zöllnitz,
Germany) into the cytoplasm of the zygotes with an injec-
tion pressure of 120 hPA (Ph: 80 hPA) using an Axiovert
135 microscope (Zeiss, Göttingen, Germany) with Trans-
ferMan NK2 and FemtoJet (Eppendorf, Hamburg,
Germany). Injected zygotes were incubated over night in
an incubator at 37°C, 5% CO2 and 95% humidity. Mor-
phologically intact one-cell and two-cell embryos weretransferred the next day into the oviducts of day 0.5 pseu-
dopregnant (LEW x WKY) F1 rats [42].
Mutation detection
Rag1 from the putative founder animals and from wild
type LEW rats was amplified with the OptimaseW Poly-
merase (Transgenomic, Glasgow, UK) and the primer
pair Cel-I forward 5’-CTCATTGCCAGAGTTTTCCG-‘3
and Cel-I reverse 5’-TGCTGACCCTAGCCTGAGTT-‘3
using the following PCR protocol: 95°C for 5 min,
34 cycles: 95°C for 30 sec, 60°C for 30 sec, 72°C for 1
min); 72°C for 5 min, 4°C ∞. The resulting 310 bp frag-
ments covering the ZFN cut site was hybridized and
digested with the SURVEYORW Mutation Detection
Assay (Transgenomic, Glasgow, UK) following the sup-
plier’s instruction. Cel-I digestion of heteroduplex DNA
derived from Rag1 mutated animals resulted in cleavage
of the 310 bp PCR product into 174 bp and 136 bp frag-
ments. Rag1 mutation was confirmed by sequencing of
genomic DNA and PCR products with the ABI 310 Gen-
etic Analyzer (Applied Biosystems, Darmstadt, Germany)
using the BigDyeW Terminator v1.1 Cycle Sequencing
Kit (Applied Biosystems, Darmstadt, Germany).
Performing blast search 10 genomic loci showing
strong homology to the ZFN binding and cut site of
Rag1 were identified. Off-target mutations at these loci
were excluded by PCR amplification at an annealing
temperature of 58°C followed by Cel-I digest using the
SURVEYORW Mutation Detection Assay (Transgenomic,
Glasgow, UK) (Oligonucleotides see Additional file 1.
Genotyping
The genotype of LEW/Ztm-Rag1em1Ztm rats was determined
by PCR amplification of a 1052 bp fragment of Rag1 with
the primer pair Rag1for1: 5’-AGGTAGCTTCGCCAAA.
ATGG-‘3 and Rag1rev1: 5’-TCAGAAAGGACTT-
GACCGGA-‘3 using the HotStarTaq Master Mix Kit
(Qiagen, Hilden, Germany) following the manufacturer’s
recommendations. PCR were performed in a volume of
50 μl according to the following protocol: 95°C for
15 min; 40 cycles: 95°C for 15 sec, 60°C for 30 sec, 72°C
for 1 min; 72°C for 5 min; 4°C ∞. After reaction clean
up with the Qiaquick Gel Extraction Kit (Qiagen, Hil-
den, Germany) the PCR products containing the Rag1
mutation were cleaved by StyI-HF (NEB, Frankfurt, Ger-
many) into 603 bp and 449 bp, while the wild type Rag1
fragments remained unchanged.
RNA and RT-PCR
Total RNA was isolated from spleen, thymus, bone mar-
row and lymph nodes (mesenteric and cervical) from
wild type LEW/Ztm rats, heterozygous and homozygous
Rag1 mutant rats (n=10) using the RNeasy Mini Kit
(Qiagen, Hilden, Germany) after homogenization of the
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Teltow, Germany) and Qiashredder (Qiagen, Hilden,
Germany). RNA concentrations were determined with
the Nanodrop spectrophotometer (Peqlab, Erlangen,
Germany). 2 μg of pooled RNA were transcribed to
cDNA with the Omniscript RT Kit (Qiagen, Hilden,
Germany), Random Hexamers (Fermentas, St. Leon-Rot,
Germany) and Protector Rnase Inhibitor (Roche, Mann-
heim, Germany). Rat GAPDH was amplified with the
following primers 5’-AGGGCTGCCTTCTCTTGTGAC-
‘3 and 5’-CCGTGGGTAGAGTCATAC TGG-‘3 with an
annealing temperature of 57°C for 25 cycles using the
HotStarTaq Master Mix Kit (Qiagen, Hilden, Germany).
Expression of wild type and mutated Rag1 was deter-
mined using the genotyping protocol.
Western blot
Whole cell protein extracts were isolated from spleen,
thymus, bone marrow and lymph nodes (mesenteric and
cervical) from wild type, heterozygous, and Rag1 defi-
cient rats (n=10) with NP40 buffer supplemented with
Complete Mini Protease Inhibitor Cocktail Tablets
(Roche, Mannheim, Germany), sodium orthovanadate
(NEB, Frankfurt, Germany), PMSF (Sigma-Aldrich,
Seelze, Germany) and DTT (Sigma-Aldrich, Seelze,
Germany). Bradford Assay served to estimate the protein
concentration. 50 μg of protein supplemented with 5x
LSB loading dye was separated in a 10% gel by SDS-
PAGE and transferred to Optitran BA-S85 membrane by
semi-dry blotting. After blocking for 1 hour at room
temperature with blocking solution (5% dry milk (Carl
Roth, Karlsruhe, Germany) and 2,5% BSA, fraction V
(Sigma-Aldrich, Seelze, Germany) in 3% TBS-Tween, pH
7,4) the membrane was incubated with the first antibody
diluted in blocking solution at 4°C over night. Incuba-
tion with the secondary, HRP-conjugated antibodies was
done for 1 hour at room temperature in 3% TBS-Tween,
pH 7,4. Roti-LuminW was used as chemoluminescence
substrate. For detection of the Rag1 protein a 1:300 dilu-
tion of the RAG-1 antibody (sc-5599, SCBT, LaJolla,
CA) was sufficient followed by incubation with a 1:2500
dilution of a donkey anti rabbit secondary antibody
(ab16284, Abcam, Cambridge, UK). GAPDH expression
was demonstrated with a 1:300 dilution of the anti-
GAPDH antibody (OBT1636, AbD Serotec, Düsseldorf,
Germany) in combination with a 1:5000 dilution of the
rabbit anti mouse antibody (STAR13B, AbD Serotec,
Düsseldorf, Germany).
Histology and thymus weight
Tissues were fixed in 4% formaldehyde solution for
3 days, paraffin-embedded and cut into 4 μm slices before
staining with hematoxylin and eosin. Microphotographs
were taken using a Zeiss AxioCam MRc camera andanalyzed histologically. Thymus weight was measured
using a LA230S scale (Sartorius, Göttingen, Germany).
One-way analysis of variance (ANOVA) and Bonferroni's
Multiple Comparison Test were performed using Graph
Pad Prizm Software (Version 5.0a) to determine statistical
significances with a threshold of P < 0.05.
FACS analysis
Blood was harvested from wild type, heterozygous and
Rag1 deficient rats (n=10), and lymphocytes were iso-
lated following standard procedures. Cells were incu-
bated for 30 min at 4°C with a 1:10 dilution of the anti-
CD45RA FITC (sc-53048, SCBT, LaJolla, CA) antibody
to detect B cells, while the number of T cells and natural
killer cells were determined by double staining with 1:10
dilutions of the PerCP mouse anti-rat αβ T-cell receptor
(BD Pharmingen, Heidelberg, Germany) and the mouse
anti rat CD161:FITC antibody (AbD Serotec, Düsseldorf,
Germany). Double stainings were performed using
mouse anti rat CD3:FITC/CD4:RPE dual color reagent
(DC041), mouse anti rat CD3:FITC/CD8:RPE (DC042)
and mouse anti rat CD4/CD25 (DC040) (Abd Sertec).
For CD4/CD8 double staining the antibodies mouse anti
rat CD4-Fitc (554843, BD Pharmingen) and mouse anti
rat CD8A-PE (554857, BD Pharmingen) were used.
Stained cells were measured together with unstained
cells and isotype controls stained with 1:50 dilutions of
the PerCP Mouse IgG1 κ isotype control antibody (BD
Pharmingen, Heidelberg, Germany) or the Mouse IgG
(FITC) antibody (ab37356, Abcam, Glasgow, UK) with
the FACSCalibur flow cytometer (BD Pharmingen, Hei-
delberg, Germany). ARCSIN transformation, One-way
analysis of variance (ANOVA) and Tukey’s Multiple
Comparison Test were performed using Graph Pad
Prizm Software (Version 5.0a) to determine statistical
significances with a threshold of P < 0.05.
Additional file
Additional file 1: Off-target gene loci:RAG1 ZFN mutagenesis.
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